Ultimovacs ASA: Invitation to Third quarter 2022 results webcast presentation

03 Nov 2022 08:00 CET

Oslo, 3 November 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical
stage leader in immune stimulatory vaccines for cancer, invites to a webcast
presentation of its third quarter 2022 results on Thursday 10 November 2022.

The presentation can be followed as a live webcast accessed through a link on
www.ultimovacs.com at 14:00 CET on Thursday 10 November 2022. The webcast
presentation will be available on the Ultimovacs website, and it will be
possible to post questions during the presentation through the webcast.

The report and presentation will be available on the company website from 08:00
CET the same day.

For further information, please see www.ultimovacs.com or contact:

Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507

Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632

Anne Worsøe, Head of IR & Communication
Email: anne.worsoe@ultimovacs.com
Phone: +47 906 86815

More information:
Access the news on Oslo Bors NewsWeb site